TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers
NCT05894421
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
92
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Cancer
Interventions
DRUG:
TQB2223 injection+ Penpulimab Injection
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.